London, United Kingdom

Allan Hallett


Average Co-Inventor Count = 8.9

ph-index = 1


Location History:

  • Horsham, GB (2010)
  • London, GB (2011)

Company Filing History:


Years Active: 2010-2011

Loading Chart...
2 patents (USPTO):

Title: The Innovative Mind of Allan Hallett

Introduction

Allan Hallett is a distinguished inventor based in London, GB. With a focus on pharmaceutical innovations, he has contributed significantly to the field through his inventive work. Allan holds two patents that highlight his dedication to advancing medical therapies.

Latest Patents

Allan Hallett's latest patents represent notable advancements in the areas of pain management and therapeutic interventions. One of his patents pertains to "Fused pyridine derivatives for use as vanilloid receptor antagonists for treating pain." This invention provides specific compounds that have been defined in detail within the patent documentation, aimed at improving pharmaceutical efficacy.

His second patent relates to "Compounds and compositions useful as cathepsin S inhibitors." This invention revolves around the use of a 2-cyanopyrimidine compound specifically designed to contribute to therapeutic solutions in treating various conditions.

Career Highlights

Hallett's work is anchored at Novartis AG, a global leader in the pharmaceutical industry. His role within this esteemed organization has allowed him to leverage his innovative ideas into impactful medical solutions. The patents he holds underscore his commitment to addressing complex health issues through cutting-edge research and development.

Collaborations

Throughout his career, Allan has had the privilege of collaborating with esteemed colleagues, notably Andrew James Culshaw and Peter Gull. These partnerships have fostered an environment of innovation and shared knowledge, significantly enhancing the development of effective therapeutic compounds.

Conclusion

In summary, Allan Hallett stands out as a pivotal figure in the innovation landscape of pharmaceuticals. His patents are testament to his inventive spirit and dedication to improving healthcare outcomes. With ongoing collaborations and a strong foundation at Novartis AG, Allan continues to shape the future of medical therapies through his contributions to science and invention.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…